Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

In vitro culture during retroviral transduction improves thymic repopulation and output after total body irradiation and autologous peripheral blood progenitor cell transplantation in rhesus macaques.

Loré K, Seggewiss R, Guenaga FJ, Pittaluga S, Donahue RE, Krouse A, Metzger ME, Koup RA, Reilly C, Douek DC, Dunbar CE.

Stem Cells. 2006 Jun;24(6):1539-48.

2.

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.

Seggewiss R, Loré K, Guenaga FJ, Pittaluga S, Mattapallil J, Chow CK, Koup RA, Camphausen K, Nason MC, Meier-Schellersheim M, Donahue RE, Blazar BR, Dunbar CE, Douek DC.

Blood. 2007 Jul 1;110(1):441-9.

3.

Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age.

Malphettes M, Carcelain G, Saint-Mezard P, Leblond V, Altes HK, Marolleau JP, Debré P, Brouet JC, Fermand JP, Autran B.

Blood. 2003 Mar 1;101(5):1891-7.

4.

Transplantation of autologous peripheral blood progenitor cells: impact of CD34-cell selection on immunological reconstitution.

Rutella S, Pierelli L, Sica S, Rumi C, Leone G.

Leuk Lymphoma. 2001 Nov-Dec;42(6):1207-20. Review.

PMID:
11911401
5.

Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants.

Rutella S, Rumi C, Laurenti L, Pierelli L, Sora' F, Sica S, Leone G.

Br J Haematol. 2000 Jan;108(1):105-15.

PMID:
10651733
6.

Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution.

Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, Berenson JR, Collins RH, Koup RA.

Lancet. 2000 May 27;355(9218):1875-81.

PMID:
10866444
7.

Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.

Leong CF, Habsah A, Teh HS, Goh KY, Fadilah SA, Cheong SK.

Malays J Pathol. 2008 Jun;30(1):31-6.

8.

Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults.

Mackall CL, Stein D, Fleisher TA, Brown MR, Hakim FT, Bare CV, Leitman SF, Read EJ, Carter CS, Wexler LH, Gress RE.

Blood. 2000 Jul 15;96(2):754-62.

9.

Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells.

An DS, Wersto RP, Agricola BA, Metzger ME, Lu S, Amado RG, Chen IS, Donahue RE.

J Virol. 2000 Feb;74(3):1286-95.

10.

Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning.

Rosenzweig M, MacVittie TJ, Harper D, Hempel D, Glickman RL, Johnson RP, Farese AM, Whiting-Theobald N, Linton GF, Yamasaki G, Jordan CT, Malech HL.

Blood. 1999 Oct 1;94(7):2271-86.

11.

Phenotypic and functional lymphocyte recovery after CD34+-enriched versus non-T cell-depleted autologous peripheral blood stem cell transplantation.

Nachbaur D, Kropshofer G, Heitger A, Lätzer K, Glassl H, Ludescher C, Nussbaumer W, Niederwieser D.

J Hematother Stem Cell Res. 2000 Oct;9(5):727-36.

PMID:
11091497
12.

Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).

Uharek L, Glass B, Zeis M, Dreger P, Steinmann J, Löffler H, Schmitz N.

Exp Hematol. 1998 Feb;26(2):93-9.

PMID:
9472798
13.

Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.

Martínez C, Urbano-Ispizua A, Rozman C, Marín P, Rovira M, Sierra J, Montfort N, Carreras E, Montserrat E.

Exp Hematol. 1999 Mar;27(3):561-8.

PMID:
10089920
14.
15.

Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M.

N Engl J Med. 2002 Apr 18;346(16):1185-93.

16.

In vitro T lymphopoiesis: a model system for stem cell gene therapy for AIDS.

Rosenzweig M, Marks DF, Hempel D, Johnson RP.

J Med Primatol. 1996 Jun;25(3):192-200.

PMID:
8892040
17.

Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.

Schwinger W, Weber-Mzell D, Zois B, Rojacher T, Benesch M, Lackner H, Dornbusch HJ, Sovinz P, Moser A, Lanzer G, Schauenstein K, Ofner P, Handgretinger R, Urban C.

Br J Haematol. 2006 Oct;135(1):76-84.

PMID:
16925797
18.

CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection.

Damiani D, Stocchi R, Masolini P, Michelutti A, Geromin A, Sperotto A, Skert C, Michieli M, Baccarani M, Fanin R.

Ann Oncol. 2003 Mar;14(3):475-80.

PMID:
12598356
19.

Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates.

Kim HJ, Tisdale JF, Wu T, Takatoku M, Sellers SE, Zickler P, Metzger ME, Agricola BA, Malley JD, Kato I, Donahue RE, Brown KE, Dunbar CE.

Blood. 2000 Jul 1;96(1):1-8.

20.

Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.

Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE.

Blood. 1998 Aug 15;92(4):1131-41.

Supplemental Content

Support Center